Skip to main content
. 2020 May 25;77(22):4581–4600. doi: 10.1007/s00018-020-03550-7

Table 2.

INF2-related disease cases and mutations grouped by exon

Exon (%) 2 3 4 6 Total
Cases Mutations Cases Mutations Cases Mutations Cases Mutations Cases Mutations
40 (29.0) 30 (44.1) 19 (13.8) 14 (20.6) 74 (53.6) 20 (29.4) 5 (3.6) 4 (5.9) 138 68
Disease
 FSGS 15 12 10 9 67 20 5 4 97 45
 FSGS + CMT 21 16a 8 5a 4 2a 0 0 33 23
 Other 4 4 1 1 3 3b 0 0 8 8
Inheritance
 Familial 18 15 16 12 62 18 3 3 99 48
 Sporadic 20 15c 3 3c 7 4c 0 0 30 22
 Not determined 2 3d 0 0 5 4d 2 2d 9 9

aIncludes mutations (C104W, R106P, C151R; V181G, E184K) that can cause isolated FSGS and not only FSGS + CMT or FSGS/FSGS + CMT

bIncludes mutations (R177H, E184K, E220K) that can cause FSGS and not only “others”

cIncludes mutations (G114D, L132R, E184K, R218Q, E220K) that can cause familial disease and not only sporadic cases

dIncludes mutations (L42P, R106P, R177H, R218Q, E220K, S263A) that can cause sporadic or familial disease and not only “not determined” cases